pharmacy
Zanamivir:
A ❏ reduces replication of influenza A and B viruses
B ❏ reduces duration of influenza symptoms by 3 days
C ❏ is licensed for prophylaxis of influenza
D ❏ is available as capsules
E ❏ is licensed for use within 72 h of the first symptoms
The answer is A, and Abbas Abdulraheem is winner.
Zanamivir is an antiviral agent used in influenza because it reduces replication
of influenza A and B viruses by inhibiting the viral enzyme neuraminidase.
It normally reduces the duration of symptoms by around 1–1.5 days.
Zanamivir is not licensed for prophylaxis of influenza. It is indicated for the
treatment of influenza and should be started within 48 h of the first symptoms.
It is available as a dry powder for inhalation.
Comment:A
Comment:A
Comment:D
À
A